Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Obstructive Lung Diseases

Free Subscription 06.05.2024 2 Allergy 3 Am J Respir Cell Mol Biol 3 Am J Respir Crit Care Med 1 Arch Bronconeumol 3 BMC Pediatr 1 Clin Exp Allergy 2 Eur Respir J 1 J Allergy Clin Immunol 2 J Asthma 7 Pediatr Pulmonol 1 Pediatrics 9 Respir Med 2 Respir Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Allergy

1. HALVARD HANSEN ES, Kaiser H, Hansen KT, Bonnelykke K, et al
   Association between Apgar scores within normal range and development of asthma, allergic rhinitis and eczema in childhood: A Danish nationwide register study.
   Allergy. 2024 Apr 27. doi: 10.1111/all.16143.
   PubMed        
   
   
2. ROTH-WALTER F, Adcock IM, Benito-Villalvilla C, Bianchini R, et al
   Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology.
   Allergy. 2024;79:1089-1122.
   PubMed         Abstract available
   
   

   
   Am J Respir Cell Mol Biol

3. SEOW CY
   SRF Overexpression, A Double Trouble that May Underlie Airway Hyperresponsiveness in Asthma.
   Am J Respir Cell Mol Biol. 2024 May 2. doi: 10.1165/rcmb.2024-0168.
   PubMed        
   
   
4. DONOVAN C, Thorpe AE, Gomez HM, Carroll OR, et al
   The GPR84 Antagonist GLPG1205 Reduces Features of Disease in Experimental Severe Asthma.
   Am J Respir Cell Mol Biol. 2024;70:424-427.
   PubMed        
   
   
5. KHALENKOW D, Brandsma CA, Timens W, Choy DF, et al
   Alternative Splicing Is a Major Factor Shaping Transcriptome Diversity in Mild and Severe Chronic Obstructive Pulmonary Disease.
   Am J Respir Cell Mol Biol. 2024;70:414-423.
   PubMed         Abstract available
   
   

   
   Am J Respir Crit Care Med

6. CHOI B, Liu GY, Sheng Q, Amancherla K, et al
   Proteomic Biomarkers of Quantitative Interstitial Abnormalities in COPDGene and CARDIA Lung Study.
   Am J Respir Crit Care Med. 2024;209:1091-1100.
   PubMed         Abstract available
   
   
7. GIRODET PO
   Strategies for Identifying Biomarkers in Severe Asthma.
   Am J Respir Crit Care Med. 2024 May 3. doi: 10.1164/rccm.202404-0707.
   PubMed        
   
   
8. PEREZ-DE-LLANO L, Scelo G, Tran TN, Le TT, et al
   Exploring Definitions and Predictors of Severe Asthma Clinical Remission Post-Biologic in Adults.
   Am J Respir Crit Care Med. 2024 May 3. doi: 10.1164/rccm.202311-2192.
   PubMed         Abstract available
   
   

   
   Arch Bronconeumol

9. ALVAREZ-GUTIERREZ FJ, Casas-Maldonado F, Soto-Campos G, Blanco-Aparicio M, et al
   Spanish Consensus on Remission in Asthma (REMAS).
   Arch Bronconeumol. 2024 Apr 23:S0300-2896(24)00109.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

10. CHEN X, Han P, Kong Y, Shen K, et al
    The relationship between changes in peak expiratory flow and asthma exacerbations in asthmatic children.
    BMC Pediatr. 2024;24:284.
    PubMed         Abstract available
    
    
11. WEN X, Zhang X, Qiu Y, Wang Y, et al
    The Minhang Pediatric Biobank cohort study: protocol overview and baseline characteristics.
    BMC Pediatr. 2024;24:282.
    PubMed         Abstract available
    
    
12. TAO M, Zhang Y, Ding L, Peng D, et al
    Risk factors of sleep-disordered breathing and poor asthma control in children with asthma.
    BMC Pediatr. 2024;24:288.
    PubMed         Abstract available
    
    

    
    Clin Exp Allergy

13. SARIPALLI KR, Sieow N, Chan YH, Chan W, et al
    Treatable traits in an Asian difficult asthma cohort.
    Clin Exp Allergy. 2024 May 2. doi: 10.1111/cea.14488.
    PubMed        
    
    

    
    Eur Respir J

14. LIU T, Prescott WG, Zhou X
    Advances in Non-Type 2 Asthma in the Severe Cases: from molecular insights to novel treatment strategies.
    Eur Respir J. 2024 May 2:2300826. doi: 10.1183/13993003.00826-2023.
    PubMed         Abstract available
    
    
15. ELBEHAIRY AF, Marshall H, Naish JH, Wild JM, et al
    Advances in COPD imaging using CT and MRI: linkage with lung physiology and clinical outcomes.
    Eur Respir J. 2024;63:2301010.
    PubMed         Abstract available
    
    

    
    J Allergy Clin Immunol

16. BARTELS CM, Chen Y, Powell WR, Rosenkranz MA, et al
    Alzheimer's Incidence and Prevalence with and without Asthma: A Medicare cohort study.
    J Allergy Clin Immunol. 2024 Apr 24:S0091-6749(24)00406.
    PubMed         Abstract available
    
    

    
    J Asthma

17. LIU J, Sun Y, Tian C, Qin D, et al
    Deciphering Cuproptosis-related Signatures in Pediatric Allergic Asthma using Integrated scRNA-seq and Bulk RNA-seq Analysis.
    J Asthma. 2024 Apr 30:1-12. doi: 10.1080/02770903.2024.2349596.
    PubMed         Abstract available
    
    
18. JIMENEZ-GOMEZ M, Diaz-Campos RM, Gimeno-Diaz-De-Atauri A, Fernandez-Rodriguez C, et al
    Early response to Tezepelumab in type-2 severe asthma patients non-responders to other biological treatments: a real-life study.
    J Asthma. 2024 Apr 30:1-7. doi: 10.1080/02770903.2024.2349605.
    PubMed         Abstract available
    
    

    
    Pediatr Pulmonol

19. BRISCA G, Strati MF, Buratti S, Mariani M, et al
    The increase of bronchiolitis severity in the 2022-2023 season in an Italian tertiary children's hospital: An isolated phenomenon or a warning sign?
    Pediatr Pulmonol. 2024;59:1236-1245.
    PubMed         Abstract available
    
    
20. DROUIN E, Charkaluk ML
    How old is bronchiolitis?
    Pediatr Pulmonol. 2024;59:1489-1492.
    PubMed        
    
    
21. NASSIKAS NJ, Luttmann-Gibson H, Rifas-Shiman SL, Oken E, et al
    Acute exposure to pollen and airway inflammation in adolescents.
    Pediatr Pulmonol. 2024;59:1313-1320.
    PubMed         Abstract available
    
    
22. PRESTI S, Manti S, Gammeri C, Parisi GF, et al
    Epidemiological shifts in bronchiolitis patterns and impact of the COVID-19: A two-season comparative study.
    Pediatr Pulmonol. 2024;59:1298-1304.
    PubMed         Abstract available
    
    
23. MEOLI A, Trischler J, Hutter M, Dressler M, et al
    Impulse oscillometry bronchodilator response in preschool children.
    Pediatr Pulmonol. 2024;59:1321-1329.
    PubMed         Abstract available
    
    
24. KANNIKESWARAN N, Ehrman RR, Spencer P, Pitman-Hunt C, et al
    Impact of initial high flow nasal cannula flow rates on clinical outcomes in children with bronchiolitis.
    Pediatr Pulmonol. 2024;59:1281-1287.
    PubMed         Abstract available
    
    
25. CHAPARRO-REYES CA, Fajardo-Quevedo LDC, Restrepo-Gualteros SM, Sossa-Briceno MP, et al
    Validation of the Spanish version of the Pediatric Asthma Severity Score (PASS) in a population of Hispanic children.
    Pediatr Pulmonol. 2024 May 2. doi: 10.1002/ppul.27033.
    PubMed         Abstract available
    
    

    
    Pediatrics

26. BYRD C, Noelck M, Kerns E, Bryan M, et al
    Multicenter Quality Collaborative to Reduce Overuse of High-Flow Nasal Cannula in Bronchiolitis.
    Pediatrics. 2024;153:e2023063509.
    PubMed         Abstract available
    
    

    
    Respir Med

27. GOTO T, Hernandez CG, Tsujimoto Y, Kitagawa T, et al
    Are biologics effective on lung hyperinflation in patients with resistant asthma?
    Respir Med. 2024 Apr 30:107652. doi: 10.1016/j.rmed.2024.107652.
    PubMed        
    
    
28. CAZZOLA M, Maniscalco M
    Are biologics effective on lung hyperinflation in patients with resistant asthma? A reply.
    Respir Med. 2024 Apr 26:107653. doi: 10.1016/j.rmed.2024.107653.
    PubMed        
    
    
29. JI H, Tan LD, Hafzella G, Nguyen N, et al
    Navigating Biologic Therapies in Elderly Asthma.
    Respir Med. 2024 Apr 26:107655. doi: 10.1016/j.rmed.2024.107655.
    PubMed         Abstract available
    
    
30. ZHOU Y, Duan S, Zhang L, Peng F, et al
    Cost-effectiveness analysis of fluticasone furoate/umeclidinium bromide/vilanterol and umeclidinium bromide/vilanterol in the management of moderate and severe COPD in China.
    Respir Med. 2024;226:107632.
    PubMed         Abstract available
    
    
31. BETANCOR D, Barroso B, Valverde-Monge M, Gomez-Lopez A, et al
    The discrepancy in bronchodilator response between ATS/ERS 2021 and 1991 criteria.
    Respir Med. 2024;226:107609.
    PubMed        
    
    
32. STOUSTRUP AL, Janssen DJA, Nakken N, Wouters EFM, et al
    Association of inadequate social support and clinical outcomes in patients with chronic obstructive pulmonary disease - A cross-sectional study.
    Respir Med. 2024;226:107625.
    PubMed         Abstract available
    
    
33. LUNDELL S, Isaksson U, Coe AB, Harrison SL, et al
    Swedish translation and psychometric testing of the Self-Conscious Emotions in COPD Questionnaire.
    Respir Med. 2024;226:107624.
    PubMed         Abstract available
    
    
34. LUU B, Chinnadurai A, Choudhary O, Breede N, et al
    A comprehensive evaluation of online inhaler use techniques for obstructive airway disease.
    Respir Med. 2024;226:107607.
    PubMed         Abstract available
    
    
35. ZYSMAN M, Coquelin A, Le Guen N, Solomiac A, et al
    Prevalence and disparities in influenza vaccination among patients with COPD: A French nationwide population study.
    Respir Med. 2024;226:107606.
    PubMed         Abstract available
    
    

    
    Respir Res

36. XU MM, Kang JY, Wang QY, Zuo X, et al
    Melatonin improves influenza virus infection-induced acute exacerbation of COPD by suppressing macrophage M1 polarization and apoptosis.
    Respir Res. 2024;25:186.
    PubMed         Abstract available
    
    
37. SHARMA E, Lauten K, Zebrak KA, Edwards KC, et al
    Respiratory symptoms and outcomes among cigar smokers: findings from the Population Assessment of Tobacco and Health (PATH) study waves 2-5 (2014-2019).
    Respir Res. 2024;25:185.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.